ClinicalTrials.gov record
A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon
COMPLETED · NCT00498615
Trial record
NCT IDNCT00498615
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE3
Enrollment
17
Conditions
Raynaud, Scleroderma
Interventions
Fasudil
Locations
Johns Hopkins University, Baltimore, Maryland, United States
Indexed topics
Last update
2014-11-03